反応式
[NH2:1][C:2]1[CH:7]=[C:6]([C:8]#[N:9])[C:5](B2OC(C)(C)C(C)(C)O2)=[CH:4][N:3]=1.Br[C:20]1[N:25]=[C:24]([N:26]2[CH2:31][CH2:30][O:29][CH2:28][CH2:27]2)[N:23]=[C:22]([NH:32][C:33]2[CH:34]=[N:35][C:36]3[C:41]([CH:42]=2)=[CH:40][CH:39]=[CH:38][CH:37]=3)[CH:21]=1.C([O-])([O-])=O.[Na+].[Na+]>O1CCOCC1.C1C=CC([PH+]([C]2[CH][CH][CH][CH]2)C2C=CC=CC=2)=CC=1.C1C=CC([PH+]([C]2[CH][CH][CH][CH]2)C2C=CC=CC=2)=CC=1.C(Cl)Cl.Cl[Pd]Cl.[Fe]>[NH2:1][C:2]1[CH:7]=[C:6]([C:5]([C:20]2[CH:21]=[C:22]([NH:32][C:33]3[CH:34]=[N:35][C:36]4[C:41]([CH:42]=3)=[CH:40][CH:39]=[CH:38][CH:37]=4)[N:23]=[C:24]([N:26]3[CH2:27][CH2:28][O:29][CH2:30][CH2:31]3)[N:25]=2)=[CH:4][N:3]=1)[C:8]#[N:9]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 120 °C
実験手順
To the crude 2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-4-carbonitrile (prepared as in Method 11) (25 mg, 0.13 mmol) solution in dioxane (1.8 mL) in a pressure vessel, was added (6-bromo-2-morpholin-4-yl-pyrimidin-4-yl)-quinolin-3-yl-amine (19.4 mg, 0.05 mmol) and aq. Na2CO3 (2 M, 0.6 mL, 1.2 mmol). After purging the reaction mixture with argon, dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (10.3 mg, 0.01 mmol) was added in one portion. The pressure vessel was sealed and the mixture was heated in a microwave at 120° C. for 900 seconds. The crude mixture was filtered and concentrated under reduced pressure. The crude product was purified by reverse phase preparative HPLC to give 2-amino-5-[2-morpholin-4-yl-6-(quinolin-3-ylamino)-pyrimidin-4-yl]-isonicotinonitrile (4.5 mg, 20%). LC/MS (m/z): 425.0 (MH+), Rt 2.03 minutes.
後処理
- additionwas added in one portion
- customThe pressure vessel was sealed
- filtrationThe crude mixture was filtered
- concentrationconcentrated under reduced pressure
- customThe crude product was purified by reverse phase preparative HPLC
出典と根拠
- ORDレコード
- ord-60d381057df44437bfbfcd3d9da6da70
- 出典データセット
- uspto-grants-2012_07
- 特許番号
- US08217035B2
関連ノート
読み込み中…